Pharmacists can make a critical difference in compliance with dual antiplatelet therapy (DAPT), particularly in the areas of adherence and prevention of premature discontinuation of therapy. This program will educate pharmacists on the recent updates to the DAPT guidelines, outcomes-related evidence supporting the use of DAPT, and the challenges associated with DAPT so that they can more comfortably respond to patients and providers.
Handouts
Slide Document19165L01_6pp.pdf
Slide Document19165L01_2pp.pdf
Financial Support By
AstraZeneca
Pharmacist
Outline the evidence based best practice for DAPT post ACS and outcomes related evidence supporting the use of DAPT Review the current guidelines with regards to the duration of DAPT, to include perspectives on continued DAPT in some high-risk individuals Identify potential barriers to medication adherence and create patient specific plans to improve long-term adherence to DAPT
Repeat Presentation
This presentation was last given on 8/18/2020 10:30 AM
Future Airings
There are no future airings of this activity scheduled at this time.
Activity Type
Knowledge
CE Broker
20-735652
Universal Activity Number
Pharmacist
0798-0000-19-165-L01-P
PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
PharmCon, Inc. is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.
In order to obtain a Statement of Credit, attendees must respond to all randomly-generated participation checks and complete a program evaluation. Attendees may immediately print their Statement of Credit or leave them stored on the website.
HARDWARE REQUIREMENTS Windows 8.1 Windows 10 Apple Mac OS X 10.13 or higher iOS 10+ Android 4.3+
SOFTWARE REQUIREMENTS Google Chrome Mozilla Firefox
Log in locally; do not log in using a VPN, cloud server, remote desktop, etc.
NETWORK REQUIREMENTS Broadband Internet Connection: T1, Hi-speed DSL or Cable 4G cellular connection
This continuing education activity is held as copyright by PharmCon. Through this notice, PharmCon. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).
Computer sharing is NOT permitted due to accreditation guidelines on activity monitoring. Credit is earned by one user per device.
.jpg)
PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
